George Sellers
Stock Analyst at Stephens & Co.
(0.52)
# 3,827
Out of 4,759 analysts
57
Total ratings
23.4%
Success rate
-27.82%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUTR Cutera | Maintains: Overweight | $10 → $5 | $0.10 | +4,981.30% | 11 | Aug 9, 2024 | |
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $41.70 | +63.07% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $139.85 | +107.37% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $49.56 | +17.03% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $67.46 | +163.86% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $16.62 | +44.40% | 6 | May 29, 2024 | |
| FNA Paragon 28 | Reiterates: Overweight | $18 | $13.03 | +38.14% | 3 | Apr 5, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $37.72 | +90.88% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $1.19 | +320.17% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $8.57 | +191.72% | 4 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $57 | $18.34 | +210.80% | 6 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $71 | $104.19 | -31.86% | 4 | May 8, 2023 |
Cutera
Aug 9, 2024
Maintains: Overweight
Price Target: $10 → $5
Current: $0.10
Upside: +4,981.30%
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $41.70
Upside: +63.07%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $139.85
Upside: +107.37%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $49.56
Upside: +17.03%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $67.46
Upside: +163.86%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $16.62
Upside: +44.40%
Paragon 28
Apr 5, 2024
Reiterates: Overweight
Price Target: $18
Current: $13.03
Upside: +38.14%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $37.72
Upside: +90.88%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $1.19
Upside: +320.17%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $8.57
Upside: +191.72%
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $18.34
Upside: +210.80%
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $104.19
Upside: -31.86%